Full video transcriptClick to expand
Auto-generated transcript of @keke.enzo's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00My first episode is episode number 5 of our new videos.
- 0:04And it is always a long time ago.
- 0:10The only thing I need to do is to create something.
- 0:11I don't know.
- 0:13I'm not gonna show you how to do it.
- 0:15It's going to be a story, it's going to be about a story that is going to be a story,
- 0:21but I highly recommend the video through this video to see.
- 0:28what was there for the first time,
- 0:30what was the question of the first time
- 0:32that people was interested in,
- 0:34but with their abilities and their abilities,
- 0:37so, I think, in general,
- 0:38the example of a soldier in school
- 0:39that had a weapon in my face that was involved
- 0:43and I thought it was a very different thing
- 0:45to see the opportunity in June,
- 0:48because I think it's very important to see
- 0:49the person.
- 0:50Here is the message I gotta say
- 0:52for the next time that the soldier in the
- 0:54second time
- 0:56process of auto-gibashu a woigita.
- 1:00It's not only a visual design, but a visual design.
- 1:04It's not a visual design, but it's a visual design.
BPC-157 and TB-500 'glow up' in 10 days: what's real?
Quick answer
The video caption implies that a product combining BPC-157 and TB-500 produced visible cosmetic results within 10 days of use, but the spoken transcript contains no coherent clinical claims. Both peptides have research interest in tissue repair and wound healing primarily in animal models, with no peer-reviewed human evidence supporting skin appearance changes on a 10-day timeline. Neither BPC-157 nor TB-500 is FDA-approved for any human therapeutic indication, and their use outside a supervised clinical setting carries unquantified safety and purity risks.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
BPC-157 access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For BPC-157 and TB-500 'glow up' in 10 days: what's real?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
beta-Thymosins
Background source for thymosin biology and tissue-repair mechanisms.
PubMed
Thymosin beta 4 and the eye: the journey from bench to bedside
Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this bpc-157 video claims cluster
Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "BPC-157 and TB-500 'glow up' in 10 days: what's real?" from DC Way. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video caption implies that a product combining BPC-157 and TB-500 produced visible cosmetic results within 10 days of use, but the spoken transcript contains no coherent clinical claims.
The reason this review is not generic is the source wording and the canonical claim label "peptides antes e depois ap s o uso do glow apenas 10 dias de uso pept." In this clip, the useful excerpt is: "My first episode is episode number 5 of our new videos." That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video caption implies that a product combining BPC-157 and TB-500 produced visible cosmetic results within 10 days of use, but the spoken transcript contains no coherent clinical claims.
FormBlends verdict
BPC-157 safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video caption implies that a product combining BPC-157 and TB-500 produced visible cosmetic results within 10 days of use, but the spoken transcript contains no coherent clinical claims. Both peptides have research interest in tissue repair and wound healing primarily in animal models, with no peer-reviewed human evidence supporting skin appearance changes on a 10-day timeline. Neither BPC-157 nor TB-500 is FDA-approved for any human therapeutic indication, and their use outside a supervised clinical setting carries unquantified safety and purity risks.
- No peer-reviewed human RCT has tested BPC-157 or TB-500 for cosmetic skin outcomes as of 2024.
- Collagen remodeling takes a minimum of 8 weeks to show measurable skin changes, per Proksch et al. (2019, Skin Pharmacology and Physiology). Ten days is biologically insufficient.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- BPC-157 decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.
Review BPC-157What You'll Learn
- No peer-reviewed human RCT has tested BPC-157 or TB-500 for cosmetic skin outcomes as of 2024.
- Collagen remodeling takes a minimum of 8 weeks to show measurable skin changes, per Proksch et al. (2019, Skin Pharmacology and Physiology). Ten days is biologically insufficient.
- BPC-157 and TB-500 are not FDA-approved for any human therapeutic use and are classified as research chemicals.
- Before-and-after social media videos cannot establish causation without controls, consistent lighting, and independent verification.
- A 2020 JAMA Internal Medicine analysis by Cohen et al. found significant purity and labeling inaccuracies in research peptide and supplement products sold online.
- The spoken transcript of this video contains no coherent medical or scientific claims, meaning the entire implied argument rests on caption text and hashtags alone.
- Anyone considering peptide therapy should consult a licensed physician and review available human safety data, not a TikTok caption.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @keke.enzo actually say?
Honestly, it's hard to pin down a specific claim here because the transcript is largely incoherent. The video caption does the heavy lifting: @keke.enzo implies visible skin or body transformation results from using an unspecified "Glow" product containing BPC-157 and TB-500, achieved in "apenas 10 dias" (just 10 days). The spoken content references stories, soldiers, and visual design in a way that doesn't map to any coherent peptide claim. So we're fact-checking the caption and hashtags, not a verbal argument, because there isn't one.
The before-and-after framing is the real claim here. It implies that whatever physical change the viewer sees on screen was caused by these peptides in under two weeks. That's a specific and testable premise, even if the creator never said it out loud.
Does the science back this up?
Not for a 10-day cosmetic transformation, no. The evidence for BPC-157 and TB-500 in humans is thin, and what exists focuses on injury healing and tissue repair, not skin "glow."
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a gastric protein. Most of the mechanistic research is in rodent models. Chang et al. (2011, Journal of Applied Physiology) showed accelerated tendon and ligament healing in rats. Human clinical trials are essentially nonexistent as of 2024. TB-500 is a synthetic fragment of Thymosin Beta-4. Goldstein et al. (2012, Annals of the New York Academy of Sciences) documented its role in actin regulation and wound healing in animal studies. Again, robust human data is missing.
Neither peptide has peer-reviewed human evidence supporting skin luminosity changes within 10 days. The timeline alone is biologically implausible for collagen remodeling, which takes weeks to months even under optimal conditions (Baumann, 2007, Clinics in Dermatology).
What did they get wrong (or right)?
The "10 days" claim is where this falls apart most clearly. Collagen synthesis and skin remodeling are slow biological processes. A 2019 review by Proksch et al. in Skin Pharmacology and Physiology found that oral collagen peptide supplementation, which has stronger human evidence than injectable BPC-157 or TB-500, showed measurable skin elasticity improvements after 8 weeks minimum. Ten days is not enough time for meaningful dermal change, regardless of the compound used.
To give some credit: BPC-157 does have legitimate research interest in wound healing and gut repair contexts. TB-500 has real science behind its role in tissue regeneration. These are not invented compounds. But "real compound" does not equal "proven for this use case," and the leap from "helps heal tendons in rats" to "gives you a skin glow in 10 days" is enormous.
- No human RCT supports BPC-157 for cosmetic skin outcomes.
- No human RCT supports TB-500 for cosmetic skin outcomes.
- The 10-day timeframe is inconsistent with known skin biology.
- Before-and-after videos without controls prove nothing about causation.
What should you actually know?
BPC-157 and TB-500 are not approved by the FDA for any therapeutic use in humans. They are sold as research chemicals and, in some cases, compounded by pharmacies under specific prescriber arrangements. Using them based on a TikTok before-and-after is a significant risk decision made with essentially zero clinical information.
The risks are real. Without pharmaceutical-grade production standards, purity and dosing accuracy in peptide compounds vary widely. A 2020 analysis by Cohen et al. in JAMA Internal Medicine found that many sports supplements and research peptides contain undisclosed ingredients or inaccurate concentrations. You cannot verify what's in a product based on a social media caption.
If you're genuinely interested in peptide therapy for recovery or skin health, that conversation belongs with a licensed physician who can review your labs, health history, and goals. A TikTok caption is not a protocol.
Bottom line on this video
The transcript is functionally uninformative. The caption makes an implied cause-and-effect claim, specifically that "Glow" with TB-500 and BPC-157 produced visible results in 10 days, that is not supported by existing human research. Before-and-after videos are not evidence. The 10-day timeline conflicts with basic skin biology. The compounds referenced have real but limited and mostly animal-model science behind them, none of which supports this specific claim. Approach with appropriate skepticism.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
DC Way · TikTok creator
1.5K views on this video
Antes e depois após o uso do Glow apenas 10 dias de uso #peptideosdecolageno #glow #tb500 #bcp157
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about no peer-reviewed human rct has tested bpc-157?
No peer-reviewed human RCT has tested BPC-157 or TB-500 for cosmetic skin outcomes as of 2024.
What does the video say about collagen remodeling takes a minimum of 8 weeks to show?
Collagen remodeling takes a minimum of 8 weeks to show measurable skin changes, per Proksch et al. (2019, Skin Pharmacology and Physiology). Ten days is biologically insufficient.
What does the video say about bpc-157?
BPC-157 and TB-500 are not FDA-approved for any human therapeutic use and are classified as research chemicals.
What does the video say about before-and-after social media videos cannot establish causation without controls, consistent?
Before-and-after social media videos cannot establish causation without controls, consistent lighting, and independent verification.
What does the video say about a 2020 jama internal medicine analysis by cohen et al.?
A 2020 JAMA Internal Medicine analysis by Cohen et al. found significant purity and labeling inaccuracies in research peptide and supplement products sold online.
What does the video say about the spoken transcript of this video contains no coherent medical?
The spoken transcript of this video contains no coherent medical or scientific claims, meaning the entire implied argument rests on caption text and hashtags alone.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by DC Way, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.